大庆招聘

Novo Nordisk is a focused healthcare company and a world leader in diabetes care. Novo Nordisk Research Centre China (NNRCC) is located in Beijing and is an integrated part of the Novo Nordisk R&D organization. Novo Nordisk wants to expand the diabetes research activities in China. Therefore a new position is being opened for a highly qualified and motivated senior scientist with expertise in pharmacology and who plans to advance a career in China.

Diabetes Research China (DRC) is part of NNRCC and function as an integrated part of Novo Nordisk Diabetes Research Unit which span research sites in Denmark, Seattle, US and Beijing. DRC is responsible for supporting the diabetes and obesity research projects in the discovery phase. Currently, DRC is composed of four departments; Pharmacology & Facility, Diabetes Pharmacology, Diabetes Biology and Histopathology. We are a highly motivated and productive team with high standards for our deliveries into the projects. We work in a state-of-the-art facility and value high team spirit, good communication and dynamic collaboration both internally and internationally. DRC is expected to grow significantly over the next years, which leads to excellent opportunities for individual development.

Main Tasks

Take responsibility in further developing the dog pharmacology at Diabetes Research China. You will plan and hands-on conduct in vivo dog pharmacology studies, perform data analysis, interpreting data and reporting results at project meetings. You are expected to supervise and mentor research associates herby promoting the collaboration culture. You are also expected to maintain state-of-the-art competencies, set-up and develop new models and new technologies. Our Research centre is growing rapidly and you will be expected to have impact on the development of our expertise area and represent the specific functional group in project teams.

You will be referring directly to the department head and your main internal contacts will be scientist colleagues, research associates, project members, and managers both in Beijing and in Denmark. Furthermore, developing and maintaining a strong external network is also going to be an important part of your work.
Qualifications

• Ph.D. within pharmacology or related sciences and with excellent scientific background
• Scientific expertise within diabetes is a plus
• 3-5+ years post-doctoral level experience in a research and/or development environment (usually acquired at Associate Scientist or Postdoctoral level)
• Experience from a pharmaceutical company is a plus.
• Minimum 2 years working experience in in vivo pharmacology
• Canine experience is a plus.
• Pharmacokinetics knowledge is a plus.
• Demonstrated scientific expertise and innovation with good track record of publication.
• Excellent oral and written communication skills, fluent in English.
• Be able to handle multi-tasks simultaneously and meet deadlines.
• Flexible, open to new ideas, innovative and result oriented.

Title and compensation will be commensurate with the applicant’s qualifications and based on benchmark in China.

　　诺和诺德是世界领先的生物制药公司，在用于糖尿病治疗的胰岛素开发和生产方面居世界领先地位。诺和诺德总部位于丹麦首都哥本哈根，员工总数30000人，分布于79个国家，产品销售遍布180个国家。在欧美均建有生产厂。
　　诺和诺德的产品60年代初就已进入中国市场。1994年初，诺和诺德董事会通过了在中国实施战略投资的计划，在北京建立诺和诺德（中国）制药有限公司总部和生物技术研究发展中心，在天津兴建现代化生产工厂，并在全国30多个城市建立了完善的营销体系。欲了解详情，请访问诺和诺德中国网站：www.novonordisk.com.cn

　　为配合公司在中国业务的迅速发展，现诚聘。

　　诺和诺德将为您提供具有竞争力的福利、完善的个人发展与培训机会，使您在国际化的管理与富有挑战性的工作环境中不断地进步与自我实现！应聘者请将个人简历、期望薪水、身份证、学历证明复印件于10日内寄至本公司。
　　请在信封上注明应聘职位。